-
Product Insights
NewToll Like Receptor 7 – Drugs In Development, 2024
The Toll Like Receptor 7 pipeline drugs market research report outlays comprehensive information on the Toll Like Receptor 7 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, Immunology, and Dermatology which include indications of Solid Tumor, Melanoma, Human Immunodeficiency Virus (HIV) Infections (AIDS), Hepatitis B, Systemic Lupus Erythematosus, Inflammation, Dermatological Disorders, and Actinic (Solar)...
-
Product Insights
NewPurinergic Receptor P2X – Drugs In Development, 2024
The Purinergic Receptor P2X pipeline drugs market research report outlays comprehensive information on the Purinergic Receptor P2X targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Respiratory, Dermatology, and Genetic Disorders which include indications of Pain, Neuropathic Pain (Neuralgia), Chronic Cough, Cough, Dermatology, Hidradenitis Suppurativa, Fragile X Syndrome, and Charcot-Marie-Tooth Disease Type I A. It...
-
Product Insights
NewAryl Hydrocarbon Receptor – Drugs In Development, 2024
The Aryl Hydrocarbon Receptor pipeline drugs market research report outlays comprehensive information on the Aryl Hydrocarbon Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Gastrointestinal, and Dermatology which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Psoriasis, Unspecified Immunological Disorders, Inflammatory Bowel Disease, Ulcerative Colitis, Atopic Dermatitis (Atopic Eczema), and Unspecified Dermatological Disorders....
-
Product Insights
NewInterleukin 15 – Drugs In Development, 2024
The Interleukin 15 pipeline drugs market research report outlays comprehensive information on the Interleukin 15 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Gastrointestinal, Dermatology, and Undisclosed which include indications of Solid Tumor, Unspecified Cancer, Celiac Disease, Eosinophilic Esophagitis, Vitiligo, Unspecified Dermatological Disorders, and Unspecified. It also reviews key players involved in Interleukin 15 targeted therapeutics...
-
Product Insights
NewMitogen Activated Protein Kinase 1 – Drugs In Development, 2024
The Mitogen Activated Protein Kinase 1 pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Musculoskeletal Disorders, and Dermatology which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Psoriasis, Autoimmune Disorders, Osteoarthritis, Ankylosing Spondylitis (Bekhterev's Disease), and Dermatology. It also...
-
Product Insights
NewSerine Peptidase Inhibitor Kazal Type – Drugs In Development, 2024
The Serine Peptidase Inhibitor Kazal Type pipeline drugs market research report outlays comprehensive information on the Serine Peptidase Inhibitor Kazal Type targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Genetic Disorders, and Dermatology which include indications of Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair), Dermatology, and Atopic Dermatitis (Atopic Eczema). It also reviews key players involved in Serine...
-
Product Insights
NewMitogen Activated Protein Kinase Interacting Kinase – Drugs In Development, 2024
The Mitogen Activated Protein Kinase Interacting Kinase pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase Interacting Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, and Dermatology which include indications of Triple-Negative Breast Cancer (TNBC), Non-Small Cell Lung Cancer, Migraine, Neuropathic Pain (Neuralgia), and Dermatology. It also...
-
Product Insights
NewMAP Kinase Interacting Serine/Threonine Protein Kinase 2 – Drugs In Development, 2024
The MAP Kinase Interacting Serine/Threonine Protein Kinase 2 pipeline drugs market research report outlays comprehensive information on the MAP Kinase Interacting Serine/Threonine Protein Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, and Dermatology which include indications of Triple-Negative Breast Cancer (TNBC), Non-Small Cell Lung Cancer, Migraine, Neuropathic Pain (Neuralgia), and Dermatology....
-
Product Insights
NewC-X-C Chemokine Receptor Type 4 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 4 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Infectious Disease, and Dermatology which include indications of Solid Tumor, Oncology, Transplant Rejection, Autoimmune Disorders, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress...
-
Product Insights
NewMu Type Opioid Receptor – Drugs In Development, 2024
The Mu Type Opioid Receptor pipeline drugs market research report outlays comprehensive information on the Mu Type Opioid Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Toxicology, Gastrointestinal, and Dermatology which include indications of Pain, Opium (Opioid) Addiction, Acute Opioid Overdosage, Opioid Induced Side Effects, Irritable Bowel Syndrome, Nausea , Pruritus, and Uremic...